13F

PRLD PRELUDE THERAPEUTICS INC

2026Q1 · CUSIP 74065P101 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
54
Δ holders QoQ
+6
Breadth percentile
Top 39%
Whale holders
34
Δ whales
+1
Inst. holding value
$105M
New positions
13
Closed positions
7
Price momentum (1Q)
Put / Call
0/1

Breadth history (34 quarters)

2020Q4: Δ+12 · h=51 2021Q1: Δ+10 · h=61 2021Q2: Δ-3 · h=58 2021Q3: Δ+2 · h=60 2021Q4: Δ+17 · h=77 2022Q1: Δ-8 · h=69 2022Q2: Δ-6 · h=63 2022Q3: Δ-9 · h=54 2022Q4: Δ+7 · h=61 2023Q1: Δ-5 · h=56 2023Q2: Δ+0 · h=56 2023Q3: Δ+5 · h=61 2023Q4: Δ-4 · h=57 2024Q1: Δ+2 · h=59 2024Q2: Δ+3 · h=62 2024Q3: Δ+9 · h=71 2024Q4: Δ-8 · h=63 2025Q1: Δ-3 · h=60 2025Q2: Δ-9 · h=51 2025Q3: Δ-4 · h=47 2025Q4: Δ+1 · h=48 2026Q1: Δ+6 · h=54 2020Q4: holders=51 2021Q1: holders=61 2021Q2: holders=58 2021Q3: holders=60 2021Q4: holders=77 2022Q1: holders=69 2022Q2: holders=63 2022Q3: holders=54 2022Q4: holders=61 2023Q1: holders=56 2023Q2: holders=56 2023Q3: holders=61 2023Q4: holders=57 2024Q1: holders=59 2024Q2: holders=62 2024Q3: holders=71 2024Q4: holders=63 2025Q1: holders=60 2025Q2: holders=51 2025Q3: holders=47 2025Q4: holders=48 2026Q1: holders=54 -17 -8.5 +0 +8.5 +17 426281 20Q421Q221Q422Q222Q423Q223Q424Q224Q425Q225Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 0 lit events

No lit events in history

Options Sentiment

Put holders
0
QoQ: -1
Call holders
1
QoQ: +1

See methodology →

Fundamentals

PE (TTM)
EPS (TTM)
$-1.00
EPS YoY
Revenue (TTM)
Revenue YoY
Quarterly Revenue & EPS (4Y)
2022-06-30: EPS -0.58 2022-09-30: EPS -0.63 2022-12-31: EPS -0.60 2023-03-31: EPS -0.58 2023-06-30: EPS -0.54 2023-09-30: EPS -0.45 2023-12-31: EPS -0.45 2024-03-31: EPS -0.42 2024-06-30: EPS -0.46 2024-09-30: EPS -0.43 2024-12-31: EPS -0.37 2025-03-31: EPS -0.42 2025-06-30: EPS -0.41 2025-09-30: EPS -0.26 2025-12-31: EPS -0.20 2026-03-31: EPS -0.13 -0.69 -0.35 0.00 20222023202420252026 EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)